Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 121 AL 135

Revisiting butyrylcholinesterase in Alzheimer's disease: A hub linking cholinergic, metabolic and affective pathways

Svobodova B, Soukup O, Korabecny J.

Ageing Res Rev. 2026 Jul;119:103187. doi: 10.1016/j.arr.2026.103187. Epub 2026 May 25.

Mesenchymal stem cell-mediated regulation of neuroinflammation and amyloid-β clearance: A promising therapeutic strategy for Alzheimer's disease

Wang Y.

J Alzheimers Dis. 2026 Jul;112(2):531-542. doi: 10.1177/13872877261451894. Epub 2026 May 27.

Comparative long-term outcomes of home-based versus institutional care in Alzheimer's disease

Tan Y, Liu Q, Wu C, Zhang C, Yao Q, Li J, Kang Y, Huang B, Gu L, Lu J, Zhu D, Sun M.

J Alzheimers Dis. 2026 Jul;112(1):483-499. doi: 10.1177/13872877261451155. Epub 2026 May 29.

Ultrasound-induced blood-brain barrier opening in Alzheimer's disease: a systematic review of clinical studies

Niknam N, Songhori N, Nekahi N, Kavian M, Khosravi F, Fard AM, Moshiri Y, Haghshenas N, Sadegh MH, Torabi P.

Aging Clin Exp Res. 2026 Jun 2;38(1):171. doi: 10.1007/s40520-026-03408-1.

Linguistic-cognitive intervention in a case of early-onset Alzheimer's disease

Souza BA, Freitas MID.

Codas. 2026 Jun 1;38(3):e20250126. doi: 10.1590/2317-1782/e20250126pt. eCollection 2026.

The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence

Chiatto LM, Buccarello L, Carota G, Calabrò RS, Rifici C, Esposito E, Ardizzone A, Caruso G.

Pharmacol Res Perspect. 2026 Jun;14(3):e70280. doi: 10.1002/prp2.70280.

Targeting inflammaging in Alzheimer's disease: molecular pathways and emerging pharmacotherapies

Alotaibi MO, Al-Kuraishy HM, Fahad EH, Abdelaziz AM, El-Saber Batiha G.

Inflammopharmacology. 2026 Jul;34(7):4445-4461. doi: 10.1007/s10787-026-02281-8. Epub 2026 Jun 8.

Repurposing antidiabetics for Alzheimer's disease and related neurodegenerative disorders: Translational challenges and role of nanoparticle-mediated CNS targeting

Alnsour L, Al-Samydai A, Sadek B, Akour A.

Biomed Pharmacother. 2026 Jul;200:119614. doi: 10.1016/j.biopha.2026.119614. Epub 2026 Jun 8.

A comprehensive exploration of the structure-activity relationships, multitarget strategies, and therapeutic mechanisms of triazole scaffolds in Alzheimer's disease

Malvankar A, Raut M, Singh SK, Singh R, Mahindroo N, Bajad N.

Future Med Chem. 2026 Jul;18(14):1925-1941. doi: 10.1080/17568919.2026.2684615. Epub 2026 Jun 9.

Semaglutide showed limited improvements in patients with Alzheimer's disease: Revisiting the evoke and evoke + clinical trials

Hölscher C.

J Alzheimers Dis. 2026 Aug;112(3):1377-1381. doi: 10.1177/13872877261458402. Epub 2026 Jun 9.

Unlocking Neuroprotection: Exercise-Induced Muscle Secretome (Myokines) as a Therapeutic Avenue Against Alzheimer's Disease Pathogenesis

Shirvani H, Pescatello LS, Eftekhari Moghadam AR, Arabzadeh E.

J Mol Neurosci. 2026 Jun 10;76(2):100. doi: 10.1007/s12031-026-02556-3.

Targeting Brain Cholesterol Homeostasis in Alzheimer's Disease: Mechanisms and Therapeutic Perspectives

Ruthirakuhan M, Taha AY, Swardfager W.

J Neurochem. 2026 Jun;170(6):e70492. doi: 10.1111/jnc.70492.

Current status and challenges in targeting circulating amyloid-β carriers for Alzheimer's disease therapy

Ren L, Luo XQ, Mi FY, Yu CY.

Neuroscience. 2026 Aug 28;610:189-197. doi: 10.1016/j.neuroscience.2026.06.009. Epub 2026 Jun 13.

Advances in nano-TCM for Alzheimer's disease: lipid-based carriers integrated with innovative delivery strategies

Deng L, Li H, Yang S, Chen F, Qiao J, Bao H, Wang X, Fang S, Xu B, Tang Z.

J Nanobiotechnology. 2026 Jun 15;24(1):794. doi: 10.1186/s12951-026-04654-1.

PCSK9 in bridging metabolism and neurodegeneration: a new paradigm for alzheimer's treatment

Sood S, Singh S, Singh TG.

Metab Brain Dis. 2026 Jun 17;41(1):137. doi: 10.1007/s11011-026-01900-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias